| Literature DB >> 32874093 |
Lorina Badger-Emeka1, Yasmeen Al-Mulhim2, Fatimah Al-Muyidi2, Maram Busuhail2, Salma Alkhalifah2, Norah AlEid2.
Abstract
BACKGROUND: The 21st century has seen a wide range of diseases resulting from zoonotic infections, of which bacterial infections have led to outbreaks of food-borne diseases. AIM: The study looks at bacterial pathogen carriage by farm rats and their antimicrobial susceptibility, with the view of providing insights for antimicrobial surveillance.Entities:
Keywords: Farm rats; bacterial pathogens; multidrug resistance
Year: 2020 PMID: 32874093 PMCID: PMC7436785 DOI: 10.1177/1178630220942240
Source DB: PubMed Journal: Environ Health Insights ISSN: 1178-6302
Distribution of bacterial species encountered in the rats and their site of entrapment.
| Bacteria isolate | Village farm 1 | Village farm 2 | Village farm 3 | |||
|---|---|---|---|---|---|---|
| Rat 1.1 | Rat 1.2 | Rat 2.1 | Rat 2.2 | Rat 3.1 | Rat 3.2 | |
| X | X | X | ||||
| X | X | X | X | |||
| X | X | |||||
| X | X | |||||
| X | X | |||||
| X | X | |||||
| X | X | X | X | X | X | |
| X | X | |||||
| X | X | |||||
| X | X | X | ||||
| X | X | X | X | X | ||
| X | X | |||||
| X | X | X | ||||
|
| X | X | X | X | ||
| X | X | X | X | |||
| X | X | |||||
| X | X | X | X | X | X | |
| X | X | X | ||||
| X | X | X | X | |||
| Unidentified[ | X | X | X | X | X | X |
Abbreviations: E. coli, Escherichia coli; S. aureus, Staphylococcus aureus; OCoNS, other coagulase-negative Staphylococcus aureus; P. aeruginosa, Pseudomonas aeruginosa; P. oryzihabitans, Pseudomonas oryzihabitans; P. mirabilis, Proteus mirabillis.
a= isolates common to two farms.
b= isolate associated with one farm.
c= isolates common to all farms.
Showing the antimicrobial susceptibility of potential pathogenic Gramme-negative bacterial isolates.
| Antibiotics | Bacterial isolates | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Ampicillin | R | R | R | R | R | S | R | R | S | S | S | S |
| Amoxicillin/clavulanic acid | S | S | R | R | R | S | R | R | R | S | S | S |
| Piperacillin/tazobactam | S | S | R | S | S | S | R | S | R | S | S | S |
| Cefotaxime | S | R | R | R | R | S | R | R | R | R | I | I |
| Ceftazidime | S | R | R | R | R | S | R | S | R | S | S | S |
| Cefepime | S | R | R | R | R | S | R | R | R | S | S | S |
| Ertapenem | S | S | S | S | R | S | R | N | R | R | S | S |
| Imipenem | S | R | S | R | S | S | S | N | S | S | S | S |
| Meropenem | S | R | S | S | R | S | S | N | S | S | R | S |
| Amikacin | S | R | S | S | R | S | S | R | S | R | S | S |
| Gentamicin | S | S | S | S | S | S | S | S | S | S | S | S |
| Ciprofloxacin | S | R | R | S | S | S | S | S | S | S | S | S |
| Norfloxacin | S | R | R | R | R | S | R | S | R | R | S | S |
| Fosofomycin | S | R | S | S | S | S | R | S | R | S | S | S |
| Nitrofurantoin | R | S | R | R | S | S | R | R | R | S | S | S |
| Trimethoprim/sulfamethoxazole | R | R | R | S | R | R | R | S | R | S | S | S |
Abbreviations: R, resistant; S, sensitive; I, intermediate; N, not given.
Showing antimicrobial susceptibility of Gramme-positive Staphylococcal isolates.
| Antibiotics | Bacteria isolates | |||||||
|---|---|---|---|---|---|---|---|---|
| CoNS Isolate 1 | CoNS Isolate 2 | |||||||
| Benzylpenicillin | R | R | R | R | R | S | R | R |
| Ampicillin | R | R | R | R | R | S | R | R |
| Amoxicillin/sulbactam | R | R | R | R | R | R | S | R |
| Cefotaxime | R | R | R | R | R | S | R | R |
| Cefuroxime axetil | R | R | R | I | R | I | R | R |
| Imipenem | I | R | R | R | R | S | I | R |
| Levofloxacin | S | S | S | S | S | S | S | S |
| Moxifloxacin | S | S | R | S | S | S | S | S |
| Erythromycin | R | R | R | R | R | I | I | S |
| Clindamycin | S | S | I | S | S | S | R | I |
| Linezolid | R | S | S | S | S | S | S | S |
| Teicoplanin | R | R | S | S | R | S | R | R |
| Vancomycin | S | S | S | S | S | S | S | S |
| Tetracycline | R | S | R | R | S | S | I | S |
| Tigecycline | S | S | I | S | S | S | I | S |
| Nitrofurantoin | R | S | S | I | S | S | S | S |
| Trimethoprim/sulfamethoxazole | S | S | S | S | S | S | S | S |
Figure 1.Showing antimicrobial susceptibility of Gramme-positive isolates against test antibiotics.
Figure 2.Showing antimicrobial susceptibility of Gramme-negative isolates.
Comparison of percentage antimicrobial susceptibility of Gramme-positive isolates with their P values.
| Bacterial isolate | Number of tested antibiotics | % resistant | % sensitive | |
|---|---|---|---|---|
| 17 | 11 (65) | 6 (35) | .002 | |
| 17 | 8 (47) | 9 (53) | .54 | |
| 17 | 11 (65) | 6 (35) | .002 | |
| 17 | 9 (53) | 8 (47) | .54 | |
| 17 | 8 (47) | 9 (53) | .54 | |
| 17 | 3 (18) | 14 (82) | .000 | |
| CoNS isolate 1 | 17 | 10 (59) | 7 (41) | .07 |
| CoNS isolate 2 | 17 | 8 (47) | 9 (53) | .54 |
Represents significant deference between resistant and sensitive isolates at P < .05.
Represents highly significant difference.
Comparison of percentage of antimicrobial susceptibility for Gramme-negative isolates with their P values.
| Bacterial isolate | Number of tested antibiotics | % resistant | % sensitive | |
|---|---|---|---|---|
| 16 | 3 (19) | 13 (81) | .00 | |
| 16 | 11(69) | 5 (31) | .001 | |
| 16 | 10 (63) | 6 (37) | .008 | |
| 16 | 8 (50) | 8 (50) | 1.00 | |
|
| 16 | 10 (63) | 6 (37) | .008 |
| 16 | 1 (6) | 15 (94) | .000 | |
| 16 | 11 (69) | 5 (31) | .0001 | |
| 16 | 6 (38) | 10 (62) | .015 | |
| 16 | 10 (63) | 6 (37) | .008 | |
| 16 | 4 (25) | 12 (75) | .0000 | |
| 16 | 2 (13) | 14 (87) | .0000 | |
| 16 | 1 (6) | 15 (94) | .0000 |
Represents significant deference between resistant and sensitive isolates at P < .05.
Represents a highly significant difference between number of antibiotic sensitive to against the number resistant to.